Eloxx Pharmaceuticals, Inc. (ELOX): Weighted Average Diluted Shares
Annual figures by period end, from SEC filings.
Stock splits: 1-for-40, first reflected in a filing dated 2023-03-31; 1-for-11, first reflected in a filing dated 2026-06-01. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.
12.35M
Year ended 2025-12-31
+78.6%
3-year compound annual growth
2021-12-31Weighted Average Diluted Shares (shares)2025-12-31